Search
Patexia Research
Case number 2023-2350

Laboratory Corporation of America Holdings v. QIAGEN Sciences, LLC > Documents

Date Field Doc. No.Description (Pages)
Aug 25, 2025 0 LABORATORY CORPORATION OF AMERICA HOLDINGS v. QIAGEN SCIENCES, LLC [OPINION] [precedential] (0)
Aug 13, 2025 63 JUDGMENT. REVERSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [1107912] [MVH] [Entered: 08/13/2025 10:32 AM] (1)
Aug 13, 2025 62 OPINION filed for the court by Lourie, Circuit Judge; Dyk, Circuit Judge and Cunningham, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [1107911] [MVH] [Entered: 08/13/2025 10:32 AM] (20)
Jun 2, 2025 61 Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Dyk, Circuit Judge and Cunningham, Circuit Judge.Arguing counsel: David Leon Bilsker for QIAGEN GmbH, QIAGEN Sciences, LLC, et al. and Edward R. Reines for General Hospital Corporation, Laboratory Corporation of America Holdings and Laboratory Genetics, Inc.Oral Argument Audio available here. [1093397] [MJL] [Entered: 06/02/2025 02:33 PM] (0)
May 8, 2025 60 Amended Response to notice of oral argument from Appellees Laboratory Corporation of America Holdings, General Hospital Corporation and Laboratory Genetics, Inc.. Service: 05/08/2025 by email. [1088335] [23-2350] [Edward Reines] [Entered: 05/08/2025 04:48 PM] (1)
May 8, 2025 59 Notice to General Hospital Corporation and Laboratory Genetics, Inc.: The record of this case indicates that no Response to Notice of Oral Argument under FCR 34(e) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [1088132] [MJL] [Entered: 05/08/2025 10:21 AM] (0)
Apr 30, 2025 58 Response to notice of oral argument from Appellee Laboratory Corporation of America Holdings. Service: 04/30/2025 by email. [1086145] [23-2350] [Edward Reines] [Entered: 04/30/2025 01:31 PM] (1)
Apr 29, 2025 57 Response to notice of oral argument from Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold. Service: 04/29/2025 by email. [1085886] [23-2350] [David Bilsker] [Entered: 04/29/2025 03:47 PM] (1)
Apr 21, 2025 56 NOTICE OF ORAL ARGUMENT. Panel: 2506C. Case scheduled June 2, 2025. Response to Notice of Oral Argument due: 05/05/2025. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1083851] [MJL] [Entered: 04/21/2025 02:55 PM] (2)
Mar 14, 2025 55 Amended Certificate of Interest for Appellees Laboratory Corporation of America Holdings, Laboratory Genetics, Inc. and General Hospital Corporation. Service: 03/14/2025 by email. [1075669] [23-2350] [Edward Reines] [Entered: 03/14/2025 06:56 PM] (4)
Mar 14, 2025 54 Amended Entry of Appearance for Edward R. Reines; Leigh J. Martinson; Daniel M. Silver; Wyley S. Proctor; Alexander T. Hornat as counsel for Appellees Laboratory Corporation of America Holdings, Laboratory Genetics, Inc. and General Hospital Corporation. Service: 03/14/2025 by email. [1075668] [23-2350] [Edward Reines] [Entered: 03/14/2025 06:51 PM] (2)
Jan 28, 2025 53 The following conflict dates submitted by David Leon Bilsker for QIAGEN GmbH, QIAGEN Sciences, LLC, et al. have been accepted by the court: 04/14/2025, 05/05/2025. [1064242] [MJL] [Entered: 01/28/2025 08:40 AM] (0)
Jan 27, 2025 52 Notice from Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold regarding conflicts with oral argument. Service: 01/27/2025 by email. [1064149] [23-2350] [David Bilsker] [Entered: 01/27/2025 04:48 PM] (5)
Oct 21, 2024 51 Amended Certificate of Interest for Appellees General Hospital Corporation, Laboratory Corporation of America Holdings and Laboratory Genetics, Inc.. Service: 10/21/2024 by email. [1041044] [23-2350] [Edward Reines] [Entered: 10/21/2024 10:06 AM] (4)
Oct 21, 2024 50 Amended Entry of Appearance for Edward R. Reines; Leigh J. Martinson; Daniel M. Silver; Wyley S. Proctor; Alexander T. Hornat as counsel for Appellees Laboratory Corporation of America Holdings, Laboratory Genetics, Inc. and General Hospital Corporation. Service: 10/21/2024 by email. [1041042] [23-2350] [Edward Reines] [Entered: 10/21/2024 10:05 AM] (2)
Oct 18, 2024 49 ORDER filed granting the motion [45] to the extent that Laboratory Corporation of America Holdings and Labcorp Genetics, Inc. are substituted for ArcherDX, LLC in this appeal. The official caption and short caption are revised as reflected in this order. Within seven days from the date of entry of this order, appellees are directed to file an amended certificate of interest and entry of appearance. The Clerk of Court shall transmit a copy of this order to the merits panel assigned to this appeal. Service as of this date by the Clerk of Court. [1040745] [LMS] [Entered: 10/18/2024 12:10 PM] (2)
Oct 16, 2024 48 The following conflict dates submitted by Edward R. Reines for General Hospital Corporation and ArcherDX, LLC have been accepted by the court: 05/06/2025, 05/07/2025, 05/08/2025, 05/09/2025, 05/12/2025. [1039862] [MJL] [Entered: 10/16/2024 08:58 AM] (0)
Oct 15, 2024 47 Notice from Appellees ArcherDX, LLC and General Hospital Corporation regarding conflicts with oral argument. Service: 10/15/2024 by email. [1039784] [23-2350] [Edward Reines] [Entered: 10/15/2024 05:38 PM] (5)
Sep 30, 2024 46 Clerk's Note to the File: The court has updated its session calendar for December 2024 through May 2025. Expected arguing counsel should review the revised calendar, available here, to determine whether to file an amended Response to Notice to Advise of Scheduling Conflicts. [1035843] [GWK] [Entered: 09/30/2024 02:26 PM] (0)
Aug 30, 2024 45 MOTION of Appellees General Hospital Corporation and ArcherDX, LLC to substitute party. Service: 08/30/2024 by email. [1029298] [23-2350] [Edward Reines] [Entered: 08/30/2024 04:33 PM] (410)
Aug 30, 2024 44 Amended Certificate of Interest for Appellees ArcherDX, LLC and General Hospital Corporation. Service: 08/30/2024 by email. [1029297] [23-2350] [Edward Reines] [Entered: 08/30/2024 04:30 PM] (4)
Aug 23, 2024 43 Amended Certificate of Interest for Appellees ArcherDX, LLC and General Hospital Corporation. Service: 08/23/2024 by email. [1027281] [23-2350] [Edward Reines] [Entered: 08/23/2024 10:14 AM] (4)
Jun 4, 2024 42 The following conflict dates submitted by David Leon Bilsker for QIAGEN GmbH, QIAGEN Sciences, LLC, et al. have been accepted by the court: 08/05/2024, 08/06/2024, 08/07/2024, 08/08/2024, 08/09/2024. [1008519] [MJL] [Entered: 06/04/2024 09:26 AM] (0)
Jun 3, 2024 41 Notice from Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold regarding conflicts with oral argument. Service: 06/03/2024 by email. [1008462] [23-2350] [Brian Cannon] [Entered: 06/03/2024 07:43 PM] (5)
May 30, 2024 40 The following conflict dates submitted by Edward R. Reines for General Hospital Corporation and ArcherDX, LLC have been accepted by the court: 12/02/2024, 12/03/2024, 12/04/2024, 12/05/2024, 12/06/2024. The following conflict dates are not accepted as pertaining to a month for which the court has already released its calendar: 07/11/2024, 07/12/2024. [1007635] [MJL] [Entered: 05/30/2024 04:21 PM] (0)
May 30, 2024 39 The following conflict dates requested by David Leon Bilsker for QIAGEN GmbH, QIAGEN Sciences, LLC, et al. (see Doc. No. [36]) are not accepted at this time: 08/05/2024, 08/06/2024, 08/07/2024, 08/08/2024, 08/09/2024. Please review the Guidance on Oral Argument Scheduling Conflicts for more information. [1007632] [MJL] [Entered: 05/30/2024 04:19 PM] (0)
May 30, 2024 38 The following conflict dates submitted by David Leon Bilsker for QIAGEN GmbH, QIAGEN Sciences, LLC, et al. have been accepted by the court: 09/03/2024, 09/04/2024, 09/05/2024, 09/06/2024, 10/11/2024. [1007630] [MJL] [Entered: 05/30/2024 04:18 PM] (0)
May 24, 2024 37 Notice from Appellees ArcherDX, LLC and General Hospital Corporation regarding conflicts with oral argument. Service: 05/24/2024 by email. [1006635] [23-2350] [Edward Reines] [Entered: 05/24/2024 11:02 PM] (6)
May 24, 2024 36 Notice from Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold regarding conflicts with oral argument. Service: 05/24/2024 by email. [1006616] [23-2350] [Brian Cannon] [Entered: 05/24/2024 06:48 PM] (5)
May 17, 2024 34 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1004920] [GWK] [Entered: 05/17/2024 12:43 PM] (1)
May 17, 2024 33 SUPPLEMENTAL BRIEF FILED by Appellees ArcherDX, LLC and General Hospital Corporation. Service: 04/24/2024 by email. [1004910] [GWK] [Entered: 05/17/2024 12:35 PM] (9)
May 17, 2024 32 ORDER filed granting the motion [25] filed by Appellees General Hospital Corporation and ArcherDX, LLC; ECF No. 25-2 is accepted for filing. The Clerk of Court shall transmit a copy of ECF No. 25-2 and this order to the merits panel assigned to this case. Service as of this date by the Clerk of Court. [1004886] [LMS] [Entered: 05/17/2024 11:58 AM] (2)
May 6, 2024 31 RESPONSE of Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold to Doc No. [25]. Service: 05/06/2024 by email. [1002383] [23-2350] [Brian Cannon] [Entered: 05/06/2024 08:07 PM] (8)
May 1, 2024 30 6 paper copies of Doc. No. [22], [21], [16] received from Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. [1001386] [VDW] [Entered: 05/01/2024 03:08 PM] (0)
May 1, 2024 29 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The paper copies (Doc No. 28) submitted by Appellees ArcherDX, LLC and General Hospital Corporation were premature. CORRECTION: Appellee's motion for leave to file a supplemental brief [25] is still pending. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [1001334] [CAB] [Entered: 05/01/2024 01:42 PM] (0)
May 1, 2024 28 Clerk's Note to the File: 6 paper copies of proposed supplemental brief received from Appellees ArcherDX, LLC and General Hospital Corporation. (Ref: motion leave to file supplemental brief, [25]) [1001324] [CAB] [Entered: 05/01/2024 01:32 PM] (0)
Apr 30, 2024 35 6 paper copies of Doc. No. [33] received from Appellees ArcherDX, LLC and General Hospital Corporation. [1004941] [VDW] [Entered: 05/17/2024 01:18 PM] (0)
Apr 29, 2024 27 6 paper copies of Doc. No. [17] received from Appellees ArcherDX, LLC and General Hospital Corporation. [1000675] [VDW] [Entered: 04/29/2024 02:20 PM] (0)
Apr 25, 2024 26 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [999924] [GWK] [Entered: 04/25/2024 10:18 AM] (0)
Apr 24, 2024 25 MOTION of Appellees ArcherDX, LLC and General Hospital Corporation leave to file a supplemental brief. Service: 04/24/2024 by email. [999865] [23-2350] [Edward Reines] [Entered: 04/24/2024 07:30 PM] (27)
Apr 23, 2024 24 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold. Service: 04/23/2024 by email. [999291] [23-2350] [Brian Cannon] [Entered: 04/23/2024 12:19 AM] (2)
Apr 22, 2024 23 MODIFIED ENTRY: APPENDIX FILED by Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V., QIAGEN Sciences, LLC and Appellees ArcherDX, LLC and General Hospital Corporation. Service: 04/22/2024 by email. [999287] --[Edited 04/24/2024 by GWK - compliance review complete] [Brian Cannon] [Entered: 04/22/2024 11:47 PM] (584)
Apr 22, 2024 22 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V., QIAGEN Sciences, LLC and Appellees ArcherDX, LLC and General Hospital Corporation. Service: 04/22/2024 by email. [999286]--[Edited 04/24/2024 by GWK - compliance review complete] [Brian Cannon] [Entered: 04/22/2024 11:43 PM] (0)
Apr 15, 2024 21 MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 04/15/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [997667] --[Edited 04/19/2024 by GWK - compliance review complete] [Brian Cannon] [Entered: 04/15/2024 10:32 PM] (35)
Mar 31, 2024 0 ARCHERDX, LLC v. QIAGEN SCIENCES, LLC [ORDER] [nonprecedential] (0)
Mar 27, 2024 20 ORDER Appeal No. 2023-2379 is dismissed. The revised official caption for the remaining appeal, Appeal No. 2023-2350, is reflected in the order. Each side shall bear its own costs as to Appeal No. 2023-2379. The motion to extend time to file brief [18] is granted. Qiagen's reply brief is due no later than 04/15/2024. The Clerk of Court shall transmit a copy of this order to the merits panel assigned to Appeal No. 2023-2350.; issuing mandate in 23-2379. Service as of this date by the Clerk of Court. [993320] [23-2350, 23-2379] [NL] [Entered: 03/27/2024 10:53 AM] (3)
Mar 22, 2024 19 Joint Stipulation of Voluntary Dismissal for Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 03/22/2024 by email. [992464] [23-2350] [Edward Reines] [Entered: 03/22/2024 02:45 PM] (1)
Mar 21, 2024 18 MOTION of Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold to extend the time to 04/15/2024 to file brief. Service: 03/21/2024 by email. [992263] [23-2350] [Brian Cannon] [Entered: 03/21/2024 06:53 PM] (7)
Mar 11, 2024 17 MODIFIED ENTRY: RESPONSE BRIEF FILED by Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 03/11/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [989903] --[Edited 03/19/2024 by KMH - compliance review complete] [Edward Reines] [Entered: 03/11/2024 06:11 PM] (75)
Dec 15, 2023 15 Amended Certificate of Interest for Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 12/15/2023 by email. [970850] [23-2350] [Brian Cannon] [Entered: 12/15/2023 10:24 PM] (3)
Dec 15, 2023 16 MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 12/15/2023 by email. [970851] --[Edited 12/20/2023 by ALK - compliance review complete] [Brian Cannon] [Entered: 12/15/2023 10:27 PM] (258)
Oct 26, 2023 14 ORDER granting motion to set briefing schedule [13] filed by Appellants. Appellant's brief is due 12/15/2023. Cross-Appellants ArcherDX, LLC and General Hospital Corporation brief is due 03/11/2024. Service as of this date by the Clerk of Court. [959305] [NL] [Entered: 10/26/2023 02:17 PM] (2)
Oct 16, 2023 13 MOTION of Appellants QIAGEN Sciences, LLC, QIAGEN LLC, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN N.V. and Jonathan Arnold to set briefing schedule. Service: 10/16/2023 by email. [956793] [23-2350] [Brian Cannon] [Entered: 10/16/2023 07:50 PM] (10)
Sep 18, 2023 12 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [4], ERROR: Plaintiff - Cross-Appellant's Entry of Appearance [4] uses a non-compliant signature format; and the contact information for Edward Reines on the form does not match the information associated with the user's account. CORRECTION: An electronic signature must follow the format prescribed by Fed. Cir. R. 25(g)(1)-(2); counsel's contact information much match the user's account, per Fed. Cir. R. 25(a)(5). Please use a compliant signature and provide matching contact information on future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [950630] [GWK] [Entered: 09/18/2023 12:08 PM] (0)
Sep 15, 2023 11 Docketing Statement for the Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 09/15/2023 by email. [950481] [23-2350] [Brian Cannon] [Entered: 09/15/2023 06:20 PM] (2)
Sep 15, 2023 10 Notice of Related Case Information for Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 09/15/2023 by email. [950479] [23-2350] [Brian Cannon] [Entered: 09/15/2023 06:19 PM] (2)
Sep 15, 2023 9 Certificate of Interest for Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 09/15/2023 by email. [950478] [23-2350] [Brian Cannon] [Entered: 09/15/2023 06:17 PM] (3)
Sep 15, 2023 8 Entry of Appearance for Brian C. Cannon; David Bilsker; Andrew Naravage as counsel for Appellants Jonathan Arnold, QIAGEN Beverly, LLC, QIAGEN Gaithersburg, LLC, QIAGEN GmbH, QIAGEN LLC, QIAGEN N.V. and QIAGEN Sciences, LLC. Service: 09/15/2023 by email. [950476] [23-2350] [Brian Cannon] [Entered: 09/15/2023 06:15 PM] (2)
Sep 15, 2023 7 Docketing Statement for the Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 09/15/2023 by email. [950465] [23-2350] [Wyley Proctor] [Entered: 09/15/2023 05:07 PM] (2)
Sep 15, 2023 6 Notice of Related Case Information for Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 09/15/2023 by email. [950464] [23-2350] [Wyley Proctor] [Entered: 09/15/2023 05:06 PM] (2)
Sep 15, 2023 5 Certificate of Interest for Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 09/15/2023 by email. [950462] [23-2350] [Wyley Proctor] [Entered: 09/15/2023 05:04 PM] (4)
Sep 15, 2023 4 Entry of Appearance for Edward R. Reines; Leigh J. Martinson; Daniel M. Silver; Wyley S. Proctor; Alexander T. Hornat as counsel for Cross-Appellants ArcherDX, LLC and General Hospital Corporation. Service: 09/15/2023 by email. [950410] [23-2350] [Wyley Proctor] [Entered: 09/15/2023 03:46 PM] (2)
Sep 12, 2023 3 Official caption revised to reflect ArcherDX, LLC and General Hospital Corporation as the Cross-Appellants. (see attached). Service as of this date by the Clerk of Court. [949529] [MMA] [Entered: 09/12/2023 03:16 PM] (2)
Sep 12, 2023 2 Note to File: The following cases are consolidated: 23-2350 (Lead) with 23-2379 (Cross-Appeal). The parties must file all documents in the lead appeal only. [949528] [23-2350, 23-2379] [MMA] [Entered: 09/12/2023 03:15 PM] (0)
Sep 1, 2023 1 Appeal docketed. Received: 08/28/2023. [947325]Entry of Appearance due 09/15/2023. Certificate of Interest is due on 09/15/2023. Docketing Statement due 09/15/2023. Appellant/Petitioner's brief is due 10/31/2023. [KMH] [Entered: 09/01/2023 12:01 PM] (57)
Menu